Gujarat Kidney & Super Speciality Share Price

Gujarat Kidney And Super Speciality Limited was incorporated under the name and style of Vihaan Medicare Private Limited, a private limited company, dated December 20, 2019 issued by the Registrar of Companies, Central Registration Centre. Subsequently, the Company name was changed to Gujarat Kidney and Super Speciality Private Limited and a fresh certificate of incorporation dated September 13, 2023 was issued by the Registrar of Companies, Gujarat at Ahmedabad. Further, Company status was changed to a public limited company and the name of Company was changed to Gujarat Kidney and Super Speciality Limited dated November 24, 2023 by the ROCs, Ahmedabad.The Company operate a chain of midsized multispecialty healthcare institution and is engaged in providing comprehensive medical services, including inpatient and outpatient care, surgical procedures, diagnostic services, and emergency care. It is one of the regional healthcare companies located in the central region of state of Gujarat. The Company categorize its healthcare services as secondary services (which are surgical services) and Tertiary Services (which are super speciality surgical services). The Hospital operates with a commitment to delivering highquality healthcare through advanced medical technology and a team of highly skilled professionals.The Company established and commenced the operations of its first hospital under the name of Gujarat Kidney Hospital at Vadodara, Gujarat in 2014 and later on expanded the bed capacity from 15 to 65 in 2018, with the establishment of 5 subspecialities in the Uro Department, viz., endourology, urologic oncology, paediatric urology, reconstructive urology, and laparoscopic urology at the Gujarat Kidney Hospital. In 2019, it set up an inhouse interventional cardiology department under the name of Gujarat Heart Care Unit for offering invasive cardiology services. In 2021, carried out its first laparoscopic radical prostatectomy at the Gujarat Kidney Hospital. The Company commenced operations of its second hospital in Godhra, Gujarat in 2023, followed by carrying its first renal transplant and first Angiography in Godhra Hospital. The Company set up 3 superspeciality departments for cardiology, urology and nephrology at the Godhra Hospital in 202324. In 2024, Company carried out its first retrograde intrarenal surgery (RIRS) at the Godhra Hospital. It acquired majority stake in Raj Palmland Hospital Private Limited, thereby making it the Subsidiary of the Company. In 2025, the Company has acquired Ashwini Medical Centre. Company has filed a Draft Prospectus and is planning to make IPO of 2,20,00,000 equity shares of face value of Rs 2/ each through fresh issue.

For the full year FY2025–2026, revenue reached ₹40.4 crore and profit touched at ₹9.5 crore.

As of 21 Jan 2026, Gujarat Kidney & Super Speciality share price is ₹101.6. The stock opened at ₹103 and had closed at ₹103.2 the previous day. During today’s trading session, Gujarat Kidney & Super Speciality share price moved between ₹100.55 and ₹103.29, with an average price for the day of ₹101.92. Over the last 52 weeks, the stock has recorded a low of ₹100.00 and a high of ₹123.00. In terms of performance, Gujarat Kidney & Super Speciality share price has declined by 10.9% over the past six months and has declined by 2.67% over the last year.